INSUBCONTINENT EXCLUSIVE:
Shares of Novartis India were last trading 6.15 per cent lower at Rs 813.35 on the BSE.Share cost of Novartis India declined around six
percent on Friday, June 18, a day after the pharmaceutical company revealed its January-March quarter results for the financial year 2020-21
On Friday, Novartis India opened on the BSE at Rs 881, swinging to an intra day high of Rs 883.35 and an intra day low of Rs 797.35, in the
trading session up until now
According to a regulatory filing by the company to the stock exchanges, Novartis India reported a profit of Rs 9.7 crore, up 43 per cent
year-on-year, in the March quarter of fiscal 2002-21
According to the declaration, the pharma company reported a net earnings of Rs 6.78 crore in the matching quarter of the previous financial
The company's earnings from operations stood at Rs 99.29 crore, compared to Rs 93.7 crore in the year-ago period.For the entire financial
year 2020-21, Novartis India's net revenue jumped two-fold to Rs 20.9 crore, compared to Rs 10.9 crore in the previous fiscal of 2019-20
The company's board of directors recommended a final dividend of Rs
10 per equity share of Rs 5 each for the financial year 2020- 2021, after the approval of shareholders.On the NSE, Novartis India opened at
Rs 875, inching to an intra day high of Rs 887.20 and an intra day low of Rs 796, in the session up until now
It was last trading 5.96 per cent lower at Rs 816.70 on the NSE.Shares of Novartis India were last trading 6.15 per cent lower at Rs 813.35
